Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 6.74% |
AMGEN INC. | AMGN | 4.63% |
GILEAD SCIENCES, INC. | GILD | 4.36% |
VERTEX PHARMACEUTICALS | VRTX | 4.08% |
REGENERON PHARMACEUTICALS | REGN | 3.71% |
CORTEVA INC | CTVA | 3.26% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.96% |
ASTRAZENECA PLC ADR | AZN | 2.07% |
NATERA INC | NTRA | 2.07% |
BEONE MEDICINES LTD-ADR | BGNE | 2.04% |
BIOGEN IDEC, INC. | BIIB | 2.03% |
INSMED INC | INSM | 2.02% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.99% |
ILLUMINA INC | ILMN | 1.89% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.73% |
MODERNA INC | MRNA | 1.71% |
UNITED THERAPEUTICS CORP | UTHR | 1.69% |
EXELIXIS, INC. | EXEL | 1.66% |
INCYTE CORP | INCY | 1.54% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.54% |
VIATRIS INC | VTRS | 1.50% |
EXACT SCIENCES | EXAS | 1.48% |
CRISPR THERAPEUTICS AG | CRSP | 1.43% |
BRIDGEBIO PHARMA INC | BBIO | 1.42% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.40% |
BLUEPRINT MEDICI | BPMC | 1.33% |
IONIS PHARMACEUTICALS, IN | IONS | 1.29% |
HALOZYME THERAPEUTICS INC | HALO | 1.26% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.22% |
ARGENX SE - ADR | ARGX | 1.22% |
BIONTECH SE-ADR | BNTX | 1.17% |
REVOLUTION MEDICINES INC | RVMD | 1.14% |
GUARDANT HEALTH INC | GH | 1.13% |
TG THERAPEUTICS | TGTX | 1.10% |
ALKERMES PLC | ALKS | 1.10% |
MEDPACE HOLDINGS | MEDP | 1.05% |
CYTOKINETICS INC | CYTK | 1.04% |
VAXCYTE INC | PCVX | 1.00% |
ROIVANT SCIENCES LTD | ROIV | 1.00% |
AVIDITY BIOSCIENCES INC | RNA | 0.92% |
AKERO THERAPEUTICS INC | AKRO | 0.90% |
ADMA BIOLOGICS INC | ADMA | 0.90% |
PTC THERAPEUTICS | PTCT | 0.89% |
VIKING THERAPEUTICS INC | VKTX | 0.89% |
PROTAGONIST THER | PTGX | 0.83% |
AXSOME THERAPEUT | AXSM | 0.82% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.76% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.74% |
SUMMIT THERAPEUTICS INC | SMMT | 0.72% |
TWIST BIOSCIENCE CORP | TWST | 0.72% |
BEAM THERAPEUTICS INC | BEAM | 0.72% |
AGIOS PHARMACEUT | AGIO | 0.72% |
KRYSTAL BIOTECH INC | KRYS | 0.71% |
CRINETICS PHARMACEUTICALS | CRNX | 0.71% |
NUVALENT INC-A | NUVL | 0.71% |
APELLIS PHARMACE | APLS | 0.69% |
VERACYTE INC | VCYT | 0.67% |
RECURSION PHARMACEUTICALS | RXRX | 0.66% |
AMICUS THERAPEUTICS INC | FOLD | 0.64% |
IDEAYA BIOSCIENCES INC | IDYA | 0.63% |
CELLDEX THERAPEUTICS INC | CLDX | 0.62% |
ULTRAGENYX PHARM | RARE | 0.61% |
INTELLIA THERAPE | NTLA | 0.60% |
DENALI THERAPEUT | DNLI | 0.58% |
ARCELLX INC | ACLX | 0.57% |
MADRIGAL PHARMAC | MDGL | 0.57% |
ASCENDIS PHA-ADR | ASND | 0.56% |
IMMUNOVANT INC | IMVT | 0.56% |
DYNAVAX TECHNOLOGY | DVAX | 0.52% |
NOVAVAX INC | NVAX | 0.46% |
SAREPTA THERAPEU | SRPT | 0.44% |
DYNE THERAPEUTICS INC | DYN | 0.34% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.23% |
GERON CORP | GERN | 0.19% |
Other (Cash, derivatives and other liabilities) | 0.20% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.